Soft-Touch Timeter® 8 LPM Flowmeter With 1 Power take Off
Soft-Touch Timeter® 8 LPM Flowmeter
Oxygen Dial Flowmeters - Chemetron
... offers a complete line of flowmeters, available i...lable in a variety of calibrations to best suit yo...specific to the gas in use, the Amvex Flowmeter is... the U with I. For Power Take-Off add PT to the en...
Medicine Products:(Date:11/25/2009)... New minimally-invasive pro...inus pain and decrease the risk of sinusitis, or s...e physicians of the Atlanta Snoring Institute. Te...and congested sinuses without having to remove any... The advantages of these breakthroughs in treating...
(Date:11/25/2009)...,, VANCOUVER,Nov.25/PRNewswire/-- AdamDreamHeal...ealingintentionschangesthephysiologyofsomeoneatadi...atatimeunknowntoavolunteerwhowasmonitoredbyaquanti...AandCanada. ,, OnNovember8inVancouver,B.C.Adami...ent.Tofocusintentions,Adamcreatedavideoclipofaspec...
(Date:11/24/2009)... Eating high amounts of salt is linked to a signi... disease, states a paper published today in the B...ied out jointly by the World Health Organization,s...University of Warwick and University Hospital in C...ion Excellence Centre in Hypertension based at the...
(Date:11/24/2009)...(Boston) Researchers from Boston University Schoo...medical Engineering Department have identified a n...distinguish between cancer and normal cells with a...earchers have developed a new computational strate...key biological pathways (molecular circuits) that ...
(Date:11/24/2009)...,, DALLAS,Nov.24/PRNewswire-USNewswire/--TheBay...rofoneofthelargestcancerclinicaltrialscooperativeg...heNationalCancerInstitute,SouthwestOncologyGroupco...s,andtoimprovethequalityoflifeforcancersurvivors. ...eradditional,importantclinicaltrialstocancerpatien...
Breaking Medicine News(10 mins):Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 2Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 3Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 4Health News:Intriguing Scientific Results from World's Largest Intention Healing Project: DreamHealer 2Health News:High salt intake linked to strokes and cardiovascular disease 2Health News:Researchers identify proteins in lung cancer cells that may provide potential drug targets 2Health News:Baylor Sammons Cancer Center Joins One of Nation's Largest Cancer Clinical Trials Groups 2...cognition to encourage Americans to think, talk an..., WHITE PLAINS, N.Y., March 3 Today, the Dannon ...tivia featuring award-winning,actress and passiona...digestive health, sheds light on this,all-too-freq...
...ersal Pictures, Drama The Express Named National, ...s 2008 Light The Night ...n, who stars in the,upcoming drama The Express as ...for The Leukemia & Lymphoma Society,s,(LLS) 2008 L...
...3 The Providence Service,Corporation (Nasdaq: PR...t,financial results for its fourth quarter and yea...2008, after the market closes., Providence will h...rporate developments. Interested parties are,invit...
... CEL-SCI CORPORATION,(Amex: CVM ) provided detail... on groundbreaking activities currently underway a...and. The facility will be used,to manufacture Mult...nts. The facility, which is being built by the des...
...b Bridges Information Gap Between Clinics and ...rael, March 3 Orthocrat Ltd, a leading,provider o...ware, will,launch its unique Orthoweb on-line serv... step forward in bridging the workflow gap between...
...mmended by Annelies Boonen of Faculty of 1000 Medi...itis is diagnosed by analysing the administrative ...thors of the paper, published in Arthritis & Rheum...lf of these patients were seen in the first three ...
Other Medicine News:Health News:Dannon Activia Launches Thought-Provoking Advertising Campaign Featuring Jamie Lee Curtis 2Health News:Dannon Activia Launches Thought-Provoking Advertising Campaign Featuring Jamie Lee Curtis 3Health News:Actor Rob Brown Rushes to Gain Ground Against Blood Cancer 2Health News:Providence Service Corporation to Report Fourth Quarter 2007 Results on Wednesday, March 12th After the Market Closes 2Health News:Providence Service Corporation to Report Fourth Quarter 2007 Results on Wednesday, March 12th After the Market Closes 3Health News:CEL-SCI CORPORATION Announces Results of 2008 Annual Meeting of Shareholders and Provides Update on Ground-breaking Activities Regarding Construction of Manufacturing Facility for Pivotal Phase III Cancer Trial 2Health News:Orthocrat to Launch On-Line Service for Storing and Sharing Pre-Operative Data at AAOS 2(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--AnadysPharmaceutica...entatthe21stAnnualPiperJaffrayHealthcareConference....TheconferenceisbeingheldatTheNewYorkPalaceHotel.S...rofAnadys,willprovideanoverviewofAnadysanditsclini...orporatepresentationwillbesimultaneouslywebcastand...
(Date:11/24/2009)...ON,Calif.,Nov.24/PRNewswire-FirstCall/--ThoratecCo...dmechanicalcirculatorysupporttherapiestosave,suppo...ticipatinginthe21stAnnualPiperJaffrayHealthCareCon...cutivevicepresidentandchieffinancialofficer,willpr...ernStandardTime(5:30a.m.,PacificStandardTime). ,...
(Date:11/24/2009)...N.C.,Nov.24/PRNewswire/--PharmaceuticalInstitute,a...epharmaceuticalandbiotechindustry,todayannouncedth...Thenew HospitalMarketplace e-courseisthenewestaddi...ries,acomprehensiveseriesofe-coursesdesignedtofill...owledgeforcommercialprofessionals. ,, Thenewthr...
Breaking Medicine Technology:Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 1 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 2 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 3 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 4 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 5 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 6 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 7 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 8 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 9Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease 3B Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver 4745 1Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease 3B Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver 4745 2Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 1Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 2Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 3Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 4